Cordova-Delgado, M.; Pinto, M.P.; Regonesi, C.; Cereceda, L.; Reyes, J.M.; Itriago, L.; Majlis, A.; RodrÃguez, P.; Fassler, A.; Mahave, M.;
et al. Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean Experience. J. Pers. Med. 2022, 12, 195.
https://doi.org/10.3390/jpm12020195
AMA Style
Cordova-Delgado M, Pinto MP, Regonesi C, Cereceda L, Reyes JM, Itriago L, Majlis A, RodrÃguez P, Fassler A, Mahave M,
et al. Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean Experience. Journal of Personalized Medicine. 2022; 12(2):195.
https://doi.org/10.3390/jpm12020195
Chicago/Turabian Style
Cordova-Delgado, Miguel, Mauricio P. Pinto, Carlos Regonesi, Luis Cereceda, José Miguel Reyes, Laura Itriago, Alejandro Majlis, Pablo RodrÃguez, André Fassler, Mauricio Mahave,
and et al. 2022. "Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean Experience" Journal of Personalized Medicine 12, no. 2: 195.
https://doi.org/10.3390/jpm12020195
APA Style
Cordova-Delgado, M., Pinto, M. P., Regonesi, C., Cereceda, L., Reyes, J. M., Itriago, L., Majlis, A., RodrÃguez, P., Fassler, A., Mahave, M., León, M. E., Gallardo, J., RodrÃguez Z., M. P., Berkovits, A., Manque, P., RÃos, J. A., Garcia-Bloj, B., & Garrido, M.
(2022). Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean Experience. Journal of Personalized Medicine, 12(2), 195.
https://doi.org/10.3390/jpm12020195
